RecallDepth
Class III Terminated

Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical Ind., Inc., NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Ltd., India.

This recall has been terminated (originally issued July 26, 2023).

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
July 5, 2023
Posted
July 26, 2023
Recall Number
D-0924-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
20,884 cartons
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.

Distribution

USA nationwide.

Lot / Code Info

Lot#: a) BAC0334A, Exp 06/2023; BAC0532A, Exp 11/2023 BAD0407A, Exp 08/2024 BAD0425A, Exp 08/2024; b) BAC0335A, Exp 06/2023, BAC0533A, Exp 10/2023, BAD0148A, Exp 03/2024, BAD0320A, Exp 07/2024

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class III Drug recalls